최하영 교수
1577-5587
전문진료분야
결핵 및 호흡기 감염, 기관지확장증, 폐암
전화 예약
1577-5587
기본정보
학력
2001 ~ 2007전남대학교 의학대학 졸업 2012 ~ 2014전남대학교 대학원 의학석사 졸업 2019 ~ 2022성균관대학교 대학원 의학박사 졸업 |
경력
2007 ~ 2010공중보건의 2010 ~ 2010Cooper University Hospital 단기연수 2011 ~ 2012전남대학교병원 인턴 2012 ~ 2016전남대학교병원 레지던트 2016 ~ 2017삼성서울병원 임상강사 2017 ~ 2018한림대학교강남성심병원 호흡기내과 임상조교수 2018 ~ 2023한림대학교강남성심병원 호흡기내과 조교수 2018 ~ 2023한림대학교 의과대학 조교수 2022 ~ 2023영국 University of Dundee 연수 2023 ~ 한림대학교 의과대학 부교수 |
학회활동
2007 ~ 대한의사협회 회원 2012 ~ 대한내과학회 회원 2015 ~ 대한결핵 및 호흡기학회 회원 2017 ~ 대한중환자의학회 회원 2019 ~ 미국흉부학회 회원 2020 ~ 유럽호흡기학회 회원 2020 ~ 대한천식알레르기학회 회원 2023 ~ Editorial Board Member of European Respiratory Journal 2024 ~ Associate Editor of ERJ Open Research |
수상이력
2019 ~ 2022미래창조과학부 생애첫연구 연구비 수혜 2019Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들 2020대한결핵 및 호흡기학회 우수 초록상 2021 ~ 2026교육부 지역대학우수과학자 연구비 수혜 2021Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들 20212nd European NTM & Bronchiectasis Workshop Best Oral Presentation 2021대한결핵 및 호흡기학회 젊은 호흡기 연구자상 2022Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(2회 선정) 2023Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(5회 선정) 20233rd European Bronchiectasis Workshop Call For Proposal Winners 수상 2024Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(2회 선정) |
논문
📌 Publications as the first author or corresponding author
1. Choi H, Hughes C, Eke Z, Shuttleworth M, Shteinberg M, Polverino E, Goeminne PC, Welte T, Blasi F, Shoemark A, Long MB, Aliberti S, Haworth CS, Ringchausen FC, Loebinger MR, Lorent N, Chalmers JD. Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study. Chest 2024 (in press).
2. Choi H, Min KH, Lee YS, Chang Y, Lee BY, Oh JY, Baek AR, Lee J, Jeon K. Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia. Tuberc Respir Dis 2024 (in press).
3. Im Y, Chalmers JD, Choi H. Disease severity and activity in bronchiectasis: A paradigm shift in bronchiectasis management. Tuberc Respir Dis 2024 (in press).
4. Choi H, Xu JF, Chotirmall SH, Chalmers JD, Morgan LC, Dhar R. Bronchiectasis in Asia: a review of current status and challenges. Eur Respir Rev 2024;33:240096.
5. Choi H, McShane PJ, Aliberti S, Chalmers JD. Bronchiectasis management in adults: state of the art and future directions. Eur Respir J 2024;63:2400518.
6. Choi H, Han K, Jung JH, Park J, Kim BG, Yang B, Eun Y, Kim H, Shin DW, Lee H. Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis. Chest 2024;165:1330.
7. Choi H, Shin J, Jung JH, Han K, Choi W, Lee HR, Yoo JE, Yeo Y, Lee H, Shin DW. Tuberculosis and osteoporotic fracture risk: development of individualized fracture risk estimation prediction model using a nationwide cohort study. Front Public Health 2024;12:1358010.
8. Kim T, Choi H, Kim SH, Yang B, Han K, Jung JH, Kim BG, Park DW, Moon JY, Kim SH, Kim TH, Yoon HJ, Shin DW, Lee H. Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study. J Korean Med Sci 2024;39:e105.
9. Choi H, Ryu S, Keir HR, Giam YH, Dicker AJ, Perea L, Richardson H, Huang JTJ, Cant E, Blasi F, Pollock J, Shteinberg M, Finch S, Aliberti S, Sibila O, Shoemark A, Chalmers JD. Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med 2023;208:1166.
10. Kim SH, Han K, Park J, Park DW, Moon JY, Sim YS, Kim TH, Kim SH, Sohn JW, Yoon HJ, Lee H, Choi H. Association between non-cystic fibrosis bronchiectasis and the risk of incident dementia: A nationwide cohort study. Chron Respir Dis 2023;20.
11. Lee H, Choi H. Female Hormone Exposure and Gastroesophageal Reflux Disease Are Also Potential Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease [Letter]. Chest 2023;164:e155.
12. Moon SM, Choi H, Kim SH, Kang HK, Park DW, Jung JH, Han K, Shin DW, Lee H. Increased Lung Cancer Risk and Associated Risk Factors in Tuberculosis Survivors: A Korean Population-Based Study. Clin Infect Dis 2023;77:1329.
13. Yang B, Kim BG, Han K, Jung JH, Kim JH, Park DW, Kim SH, Kim EG, Sohn JW, Yoon HJ, Choi H, Lee H. Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study. Arthritis Res Ther 2023;25:209.
14. Kim T, Choi H, Lee H, Han K, Park DW, Park TS, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Impact of allergic disease on the risk of mycobacterial disease. J Allergy Clin Immunol Pract 2023;11:2830.
15. Choi H, Lee JY, Yoo H, Jeon K. Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis. Int J Mol Sci 2023;24:9362.
16. Kim Y, Yoon JH, Ryu J, Yang B, Chung SJ, Kang HK, Park DW, Park TS, Moon JY, Kim TH, Kim SH, Sohn JW, Yoon HJ, Lee H, Choi H. Gastroesophageal reflux disease increases susceptibility to non-tuberculous mycobacterial pulmonary disease. Chest 2023;163:270.
17. Choi H, Han K, Jung JH, Park SH, Kim SH, Kang HK, Sohn JW, Shin DW, Lee H. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clin Infect Dis 2023;76:e973.
18. Moon SM, Choi H, Kang HK, Lee SW, Sim YS, Park HY, Kwon YS, Kim SH, Oh YM, Lee H. Impacts of asthma in patients with bronchiectasis: findings from the KMBARC registry. Allergy Asthma Immunol Res 2023;15:83.
19. Choi H, Chalmers JD. Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention. Ann Transl Med 2023;11:25.
20. Choi H, Kim SH, Han K, Park TS, Park DW, Moon JY, Kim SH, Kim TH, Sohn JW, Yoon HJ, Lee H. Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis. Respir Res 2022;23:288.
21. Choi H, Yoo J, Han K, Lee H. Reply: Epithelial Mesenchymal Plasticity as a Potential Common Link between Lung Disease and Increased Risk of Lung Cancer [Letter]. Ann Am Thorac Soc 2022;19:1788.
22. Choi H, Park HY, Han K, Yoo J, Shin SH, Yang B, Kim Y, Park TS, Park DW, Moon JY, Ra SW, Kim TH, Kim SH, Oh YM, Yoon HJ, Sohn JW, Lee H. Non-Cystic Fibrosis Bronchiectasis Increases the Risk of Lung Cancer Independent of Smoking Status. Ann Am Thorac Soc 2022:19;1551.
23. Choi H, Yoo H, Lee JY, Park J, Jeon K. Plasma Mitochondrial DNA and Necroptosis as Prognostic Indicators in Critically Ill Patients with Sepsis. Biomedicines 2022;10:2386.
24. Choi H, Han K, Yang B, Shin DW, Sohn JW, Lee H. Female reproductive factors and incidence of non-tuberculous mycobacterial pulmonary disease among postmenopausal women in Korea. Clin Infect Dis 2022;75:1397.
25. Choi H, Park HA, Hyun IG, Kim JH, Hwang YI, Jang SH, Sim YS, Shin TR, Ko Y, Ban GY, Hong JY, Lee CY, Lee MG, Choi JH. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study. Pharmacoepidemiol Drug Saf 2022;31:1153.
26. Lee H, Kim Y, Yoon JH, Choi H. Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use? A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease Response [Letter]. Chest 2023;163:e148.
27. Kim Y, Han K, Yoo J, Kang HK, Park TS, Park DW, Hong JY, Moon JY, Kim SH, Kim TH, Yoo KH, Sohn JW, Yoon HJ, Choi H, Lee H. Risk Factors of Incident Lung Cancer in Patients with Non-Cystic Fibrosis Bronchiectasis: A Korean Population-Based Study. Cancers 2022;14:2604.
28. Lee H, Choi H, Jo YS. Trends in Influenza Vaccination Rates in Participants With Airflow Limitation: The Korea National Health and Nutrition Examination Survey 2007–2018. Front Med 2022;9:870617.
29. Yang B, Han K, Kim B, Kang HK, Kim JS, Kim EG, Choi H, Lee H. Association between Smoking Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study. J Pers Med 2022;12:691.
30. Kim T, Yoon JH, Yang B, Ryu J, Yoon CK, Kim Y, Sohn JW, Lee H, Choi H. Healthcare Utilization and Medical Cost of Gastrointestinal Reflux Disease in Non-tuberculous Mycobacterial Pulmonary Disease: A Population-Based Study, South Korea, 2009–2017. Front Med 2022;9:793453.
31. Park HY, Kang D, Shin SH, Choi H, Jang SH, Lee CH, Kim H, Kwon OJ, Rhee CK, Cho J. Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2022;19:640.
32. Choi H, Lee H, Ra SW, Jang JG, Lee JH, Jhun BW, Park HY, Jung JY, Lee SJ, Jo KW, Rhee CK, Kim C, Lee SW, Min KH, Kown YS, Kim DK, Lee JH, Park YB, Chung EH, Kim YJ, Yoo KH, Oh YM. Developing a Diagnostic Bundle for Bronchiectasis in South Korea: A Modified Delphi Consensus Study. Tuberc Respir Dis 2022;85:56.
33. Yoon JH, Kim SH, Ryu J, Chung SJ, Kim Y, Yoon CK, Ra SW, Oh YM, Choi H, Lee H. Gastro-oesophageal reflux disease increases healthcare use and medical costs in patients with bronchiectasis: a Korean nationwide population-based study. Therap Adv Gastroenterol 2021;14:17562848211062801.
34. Choi H, Yoo JE, Han K, Choi W, Rhee SY, Lee H, Shin DW. Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study. Front Nutr 2021;8:739766.
35. Choi H. Nosocomial exposure to tuberculosis: a snapshot of South Korea [Editorial]. Korean J Intern Med 2021;36:1061.
36. Lee H, Choi H, Lee SK, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Predicting Factors of Severe COVID-19 in Patients With Asthma: A Korean National Cohort Study. Allergy Asthma Immunol Res 2021;13:939.
37. Choi H, Ko Y, Lee CY, Chung SJ, Kim HI, Kim JH, Park S, Hwang YI, Jang SH, Jung KS, Kim YK, Park JY. Impact of COVID-19 on TB epidemiology in South Korea. Int J Tuberc Lung Dis 2021;25:854.
38. Choi H, Lee H, Ra SW, Kim HK, Lee JS, Um SJ, Kim SH, Oh YM, Kwon YS. Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry. J Clin Med 2021;10:4542.
39. Yang B, Han K, Kim SH, Lee DH, Park SH, Yoo JE, Shin DW, Choi H, Lee H. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021;13:3206.
40. Kim T, Lee H, Sim YS, Yang B, Park HY, Ra SW, Jang HJ, Yoo SJ, Kim SH, Sohn JW, Yoon HJ, Oh YM, Kwon YS, Choi H. Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study. J Thorac Dis 2021;13:4894.
41. Yang B, Choi H, Shin SH, Kim Y, Moon JY, Park HY, Lee H. Association of Ventilatory Disorders with Respiratory Symptoms, Physical Activity, and Quality of Life in Subjects with Prior Tuberculosis: A National Database Study in Korea. J Pers Med 2021;11:678.
42. Yang B, Kim T, Ryu J, Park HY, Hwangbo B, Kong SY, Kwon YS, Lee SJ, Ra SW, Oh YM, Sohn JW, Choe KH, Choi H, Lee H. Increased Incidence and Associated Risk Factors of Aspergillosis in Patients with Bronchiectasis. J Pers Med 2021;11:422.
43. Lee H, Choi H, Yang B, Lee SK, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J 2021;58:2004125.
44. Lee H, Choi H, Chalmers JD, Dhar R, Nguyen TQ, Visser SK, Morgan LC, Oh YM. Characteristics of bronchiectasis in Korea: First data from the Korean Multcentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries. Respirology 2021;26:619.
45. Choi H, Lee JK, Oh HJ, Kim MS, Kho BG, Park CK, Oh IJ, Kim YC. Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thorac Cancer 2021;12:1598.
46. Choi H, Yang B, Kim YJ, Sin S, Jo YS, Kim Y, Park HY, Ra SW, Oh YM, Chung SJ, Yeo Y, Park DW, Park TS, Moon JY, Kim SH, Kim TH, Yoon HJ, Sohn JW, Lee H. Increased mortality in patients with non cystic fibrosis bronchiectasis respiratory comorbidities. Sci Rep 2021;11:7126.
47. Choi H, Lee H, Lee SK, Yang B, Chung SJ, Yeo Y, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study. Ther Adv Respir Dis 2021;15.
48. Yang B, Ryu J, Kim T, Jo YS, Kim Y, Park HY, Kang YA, Lee SJ, Lee OJ, Moon JY, Ra SW, Kim SH, Kim TH, Kwon YS, Oh YM, Lee KM, Sohn JW, Yoon HJ, Choi H, Lee H. Impact of Bronchiectasis on incident NTM pulmonary disease: A 10-Year national cohort study. Chest 2021;159:1807.
49. Yang B, Choi H, Lee SK, Chung SJ, Yeo Y, Shin YM, Park DW, Park TS, Moon JY, Kim TH, Sim YS, Yoon HJ, Sohn JW, Lee H, Kim SH. Risk of Coronavirus Disease Incidence, Severe Presentation, and Mortality in Patients with Lung Cancer. Cancer Res Treat 2021;53:678.
50. Lee H, Choi H, Nam H, Yang B, Hwangbo B, Kong SY, Chung SJ, Yeo Y, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Body mass index change and incident asthma in adults: A nationwide cohort study. Allergy 2021;76:1896.
51. Chung SJ, Kim HI, Yang B, Kim T, Sim YS, Kang HK, Kim SH, Yoon HJ, Choi H, Lee H. Impact of the severity of restrictive spirometric pattern on nutrition, physical activity, and quality of life: results from a nationally representative database. Sci Rep 2020;10:19672.
52. Yang B, Jang HJ, Chung SJ, Yoo SJ, Kim T, Kim SH, Shin YM, Kang HK, Kim JS, Choi H, Lee H. Factors Associated Bronchiectasis in Korea: A National Database Study. Ann Transl Med 2020;8:1350.
53. Choi H, Ryu J, Kim Y, Yang B, Hwangbo B, Kong SY, Sim YS, Park HY, Ra SW, Oh YM, Moon JY, Kim TH, Kim SH, Sohn JW, Yoon HJ, Lee H. Incidence of Bronchiectasis concerning Tuberculosis Epidemiology and Other Ecological Factors: A Korean National Cohort Study. ERJ Open Res 2020;6:00097-2020.
54. Choi H, Lee H, Ryu J, Chung SJ, Park DW, Sohn JW, Yoon HJ, Kim SH. Bronchiectasis and Increased Mortality in Patients with Corticosteroid-Dependent Severe Asthma: a nationwide population study. Ther Adv Respir Dis 2020;14.
55. Choi H, Ko Y, Lee CY. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study. BMC Cancer 2020;20:825.
56. Lee H, Sohn JW, Sim YS, Shin TR, Kim DG, Choi H. Outcomes of Extended Duration Therapy for Drug-Susceptible Cavitary Pulmonary Tuberculosis. Ann Transl Med 2020;8:346.
57. Yang B, Choi H, Chung SJ, Shin B, Lee H, Park HY. Impact of Bronchiectasis on Postoperative Pulmonary Complications after Extra-pulmonary Surgery in Patients with Airflow Limitation. J Korean Med Sci 2020;35:e80.
58. Lee H, Choi H, Sim YS, Park S, Kim WJ, Yoo KH, Lee SJ, Kim TH, Yang B, Jeong I, Um SJ, Kim DK, Lee JH, Kwon BS, Cho YJ, Park HY, Lee CH, Rhee CK, Lee SH, Na JO, Jang AS, Jung JY, Ra SW, Lee JH, Kim SH, Kim C, Kim Y, Lee CY, Kim HK, Lee JS, Lee SW, Oh YM, KMBARC. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open 2020;10:e034090.
59. Yang B, Choi H, Lim JH, Park HY, Kang D, Cho J, Lee JS, Lee SW, Oh YM, Moon JY, Kim SH, Kim TH, Sohn JW, Yoon HJ, Lee H. The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. Ann Transl Med 2019;7:770.
60. Yang B, Choi H, Kim SH, Yoon HJ, Lee H. How will nanotechnology lead to better control of asthma? [Editorial] Ann Transl Med 2019;7:515.
61. Choi H, Ko UW, Lee H, Hong SB, Chung CR. Improved survival rates in patients with H1N1 acute respiratory failure in Korea between 2009 and 2016. PLoS One 2019;14:e0223323.
62. Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, Lee JS, Lee SW, Oh YM, Ra SW, Kim SH, Sohn JW, Yoon HJ, Lee H. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54:1900194.
63. Choi H, Shin B, Yoo H, Suh GY, Cho JH, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Jeon K. Early corticosteroid treatment for postoperative acute lung injury after lung cancer surgery. Ther Adv Respir Dis 2019;13:1753466619840256.
64. Choi H, Lee H, Jeon K, Suh GY, Shin S, Kim HK, Kim K, Jeong D, Kim H. Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis. J Thorac Dis 2019;11:892.
65. Choi H, Cho JH, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Jeon K. Prevalence and clinical course of postoperative acute lung injury after esophagectomy for esophageal cancer. J Thorac Dis 2019;11:200.
66. Kim S, Choi H, Jang YJ, Park SH, Lee H. Prevalence of and factors related to latent tuberculous infection among all employees in a referral hospital. Int J Tuberc Lung Dis 2018;22:1329.
67. Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. Diagn Microbiol Infect Dis 2018;90:293.
68. Choi H, Lee H, Jeong SH, Um SW, Kown OJ, Kim H. Pulmonary actinomycosis mimicking lung cancer on positron emission tomography. Ann Thorac Med 2017;12:121.
69. Choi H, Kim SY, Lee H, Jhun BW, Park HY, Jeon K, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin SJ, Daley CL, Koh WJ. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease. Antimicrob Agents Chemother 2017;61.
70. Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin S, Shin SJ, Daley CL, Koh WJ. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease. Antimicrob Agents Chemother 2017;61.
71. Choi H, Chon HR, Kim K, Kim S, Oh KJ, Jeong SH, Jung WJ, Shin B, Jhun BW, Lee H, Park HY, Koh WJ. Clinical and Laboratory Differences between Lymphocyte- and Neutrophil-Predominant Pleural Tuberculosis. PLoS One 2016;11:e0165428.
72. Choi H, Chang J, Shin HJ, Park CK, Oh IJ, Kim KS, Kim YC. Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma. Thorac Cancer 2015;6:224.
📌 Publications as the co-author
1. Gu KM, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park JS, Kim JY. Eosinophilia is a favorable marker for pneumonia in chronic obstructive pulmonary disease. Tuberc Respir Dis 2024;87:465.
2. Lee SH, Kim YJ, Oh J, Kang H, Yoo KH, Ko BS, Lim TH, Kim BG, Lee H, Kim SH, Sohn JW, Yoon HJ, Choi H, Cho Y, Park DW. The impact of pulmonary tuberculosis on SARS-CoV-2 infection: a nationwide cohort study. Front Med 2024;11:1416197.
3. Gao Y, Richardson H, Dicker AJ, Barton A, Kuzmanova E, Shteinberg M, Perea L, Goeminne PC, Cant E, Hennayake C, Pollock J, Abo Leyah H, Choi H, Polverino E, Blasi F, Welte T, Aliberti S, Long M, Shoemark A, Sibila O, Huang JTJ, Chalmers JD. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study. Am J Respir Crit Care Med 2024;210:77.
4. Cordeiro R, Choi H, Haworth CS, Chalmers JD. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis. Chest 2024;166:61.
5. Lee JS, Yang B, Shin HS, Lee H, Chai HG, Choi H, Han JH, Yoon JH, Kim EG, Lee H. Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study. ERJ Open Res 2024;10:00087.
6. Kim SJ, Kim T, Choi H, Shin TR, Kim HI, Jang SH, Hong JY, Lee CY, Chung S, Choi JH, Sim YS. Respiratory pathogen and clinical features of hospitalized patients in acute exacerbation of chronic obstructive pulmonary disease after COVID 19 pandemic. Sci Rep 2024;14:10462.
7. Yeo Y, Yoo JE, Han K, Jung JH, Choi H, Park J, Shin DW, Lee H. Risk of dementia in survivors of acute tuberculosis in Korea: A nationwide cohort study. J Infect Public Health 2024;17:286.
8. Choi W, Moon JH, Choi H, Lee H, Kim HK, Kang HC, Cho NH. Trajectory of lung function in diabetic adults: A 16-year follow-up study of community-based prospective cohorts. Respirology 2024;29:413.
9. Lee H, Kim SH, Lee SK, Choi H, Chung SJ, Park DW, Park TS, Moon JY, Kim TH, Kim SH, Sohn JW, Yoon HJ. Impact of air pollution on healthcare utilization in patients with bronchiectasis. Front Med 2023;10:1233516.
10. Kim JY, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park JS. The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study. Korean J Intern Med 2023;38:714.
11. Yoo JE, Choi H, Han K, Park SH, Park J, Lee H, Shin DW. Tuberculosis and risk of Parkinson's disease: A nationwide cohort study. Pulmonology 2023;29:250.
12. Kim T, Kim SJ, Choi H, Shin TR, Sim YS. Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer. Cancers 2023;15:2819.
13. Lee HR, Yoo JE, Choi H, Han K, Lim YH, Lee H, Shin DW. Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study. Clin Infect Dis 2023;76:1576.
14. Kim SR, Kim SH, Kim GH, Cho JY, Choi H, Lee H, Ra SW, Lee KM, Choe KH, Oh YM, Shin YM, Yang B. Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study. Front Med 2023;10:1159227.
15. Kim SH, Kim T, Choi H, Shin TR, Sim YS. Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19. J Clin Med 2023;12:2279.
16. Kim SH, Lee H, Joo H, Choi H, Sim YS, Rhee CK, Park YB, Kim Y, Yoo KH. Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study. J Korean Med Sci 2023;38:e3.
17. Kim T, Kim SJ, Choi H, Shin TR, Sim YS. Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer. Cancers 2023;15:2819.
18. Lee HR, Yoo JE, Choi H, Han K, Lim YH, Lee H, Shin DW. Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study. Clin Infect Dis 2023;76:1576.
19. Ahn EY, Choi H, Sim YS, Shin TR, Kim T. Pulmonary embolism and inferior vena cava thrombosis in a young male patient after mRNA-1273 (Moderna) immunization: A case report. Tuberc Respir Dis 2022;85:361.
20. Kim Y, Lee H, Lee SK, Yang B, Choi H, Park DW, Park TS, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Chronic Obstructive Pulmonary Disease is Associated with a More Symptomatic Burden and Severe Presentation of COVID-19: A Korean National COVID-19 Cohort Study. Tohoku J Exp Med 2022;256:209.
21. Lee H, Chung SJ, Kim SH, Choi H, Kim Y, Park TS, Park DW, Moon JY, Kim SH, Kim TH, Yoon HJ, Sohn JW. Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease. Front Med 2022;8:801206.
22. Yang B, Lee DH, Han K, Choi H, Kang HK, Shin DW, Lee H. Female Reproductive Factors and the Risk of Bronchiectasis: A Nationwide Population-Based Longitudinal Study. Biomedicines 2022;10:303.
23. Kim SH, Choi HS, Jin ES, Choi H, Lee H, Lee SH, Lee CY, Lee MG, Kim Y. Predicting severe outcome using national early warning score (NEWS) in patients identified by a rapid response system: a retrospective cohort study. Sci Rep 2021;11.
24. Jo YS, Han K, Kim D, Yoo JE, Kim Y, Yang B, Choi H, Sohn JW, Shin DW, Lee H. Relationship between total cholesterol level and tuberculosis risk a nationwide longitudianl cohort. Sci Rep 2021;11.
25. Yoo JE, Kim D, Choi H, Kang YA, Han K, Lee H, Shin DW. Anemia, sarcopenia, physical activity, and the risk of tuberculosis in the older population: a nationwide cohort study. Ther Adv Chronic Dis 2021;12.
26. Joo H, Moon JY, An TJ, Choi H, Park SY, Yoo H, Kim CY, Jeong I, Kim JH, Koo HK, Rhee CK, Lee SW, Kim SK, Min KH, Kim YH, Jang SH, Kim DK, Shin JW, Yoon HK, Kim DG, Kim HJ, Kim JW. Revised Korean Cough Guidelines, 2020: Recommendations and Summary statements. Tuberc Respir Dis 2021;84:263.
27. Kim SH, Choi H, Lee H, Hong JY, Kim Y. Predicting unexpected deterioration of high-risk hopitalized patients during the COVID-19 pandemic: A multicenter cohort study. Resuscitation 2021;163:14.
28. Kim T, Choi H, Shin TR, Ko Y, Park YB, Kim HI, Jang SH, Jung KS, Kim Y, Lee MG, Chung S, Kim CH, Hyun IG, Sim YS. Epidemiology and clinical features of common community human coronavirus disease. J Thorac Dis 2021;13:2288.
29. Kang HK, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park J, Kim JY. Hospitalization increases while economic status deteriorates in late stages of chronic obstructive pulmonary disease: the Korean National Health and Nutrition Examination Survey for 2007–2015. J Thorac Dis 2021;13:2160.
30. Gil HI, Yang B, Lee T, Kim MY, Choi H, Yoo H, Kim H, Kwon OJ, Chung SJ, Lee H. Clinical characteristics and treatment outcomes of Candida tracheobronchitis. Medicine (Baltimore) 2021;100:e24606.
31. Lee SJ, Ju S, You JW, Jeong YY, Lee JD, Kim HC, Choi H, Lee H, Oh YM, Ra SW. Trends in the Prevalence of Non-tuberculous Mycobacterial Infection in Patients with Non-Cystic Fibrosis Bronchiectasis in South Korea, 2012-2016. Chest 2021;159:959.
32. Kim HC, Suzuki M, Lim HF, Lan LTT, Nguyen HL, Wang JS, Lee KY, Lee JS, Oh YM, Lee SD, Choi H, Lee H, Lee SW. Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations. Korean J Intern Med 2021;36:1402.
33. Kim HK, Lee H, Kim SH, Choi H, Lee JH, Lee JS, Lee SW, Oh YM. Validation of the Korean Version of the Bronchiectasis Health Questionnaire. Tuberc Respir Dis 2020;83:228.
34. Yoon SH, Choi YD, Oh IJ, Kim KS, Choi H, Chang J, Shin HJ, Park CK, Kim YC. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer. Cancer Res Treat 2015;47:661.
35. Kim WJ, Kim S, Choi H, Chang J, Shin HJ, Park CK, Oh IJ, Kim KS, Kim YC, Choi YD. Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor. Thorac Cancer 2015;6:800.
36. Kim M, Chang J, Choi H, Oh IJ, Park CK, Kim YC, Choi YD, Yun JS, Song SY, Na KJ. Pulmonary epithelioid hemangioendothelioma misdiagnosed as a benign nodule. World J Surg Oncol 2015;13:10
1. Choi H, Hughes C, Eke Z, Shuttleworth M, Shteinberg M, Polverino E, Goeminne PC, Welte T, Blasi F, Shoemark A, Long MB, Aliberti S, Haworth CS, Ringchausen FC, Loebinger MR, Lorent N, Chalmers JD. Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study. Chest 2024 (in press).
2. Choi H, Min KH, Lee YS, Chang Y, Lee BY, Oh JY, Baek AR, Lee J, Jeon K. Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia. Tuberc Respir Dis 2024 (in press).
3. Im Y, Chalmers JD, Choi H. Disease severity and activity in bronchiectasis: A paradigm shift in bronchiectasis management. Tuberc Respir Dis 2024 (in press).
4. Choi H, Xu JF, Chotirmall SH, Chalmers JD, Morgan LC, Dhar R. Bronchiectasis in Asia: a review of current status and challenges. Eur Respir Rev 2024;33:240096.
5. Choi H, McShane PJ, Aliberti S, Chalmers JD. Bronchiectasis management in adults: state of the art and future directions. Eur Respir J 2024;63:2400518.
6. Choi H, Han K, Jung JH, Park J, Kim BG, Yang B, Eun Y, Kim H, Shin DW, Lee H. Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis. Chest 2024;165:1330.
7. Choi H, Shin J, Jung JH, Han K, Choi W, Lee HR, Yoo JE, Yeo Y, Lee H, Shin DW. Tuberculosis and osteoporotic fracture risk: development of individualized fracture risk estimation prediction model using a nationwide cohort study. Front Public Health 2024;12:1358010.
8. Kim T, Choi H, Kim SH, Yang B, Han K, Jung JH, Kim BG, Park DW, Moon JY, Kim SH, Kim TH, Yoon HJ, Shin DW, Lee H. Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study. J Korean Med Sci 2024;39:e105.
9. Choi H, Ryu S, Keir HR, Giam YH, Dicker AJ, Perea L, Richardson H, Huang JTJ, Cant E, Blasi F, Pollock J, Shteinberg M, Finch S, Aliberti S, Sibila O, Shoemark A, Chalmers JD. Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med 2023;208:1166.
10. Kim SH, Han K, Park J, Park DW, Moon JY, Sim YS, Kim TH, Kim SH, Sohn JW, Yoon HJ, Lee H, Choi H. Association between non-cystic fibrosis bronchiectasis and the risk of incident dementia: A nationwide cohort study. Chron Respir Dis 2023;20.
11. Lee H, Choi H. Female Hormone Exposure and Gastroesophageal Reflux Disease Are Also Potential Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease [Letter]. Chest 2023;164:e155.
12. Moon SM, Choi H, Kim SH, Kang HK, Park DW, Jung JH, Han K, Shin DW, Lee H. Increased Lung Cancer Risk and Associated Risk Factors in Tuberculosis Survivors: A Korean Population-Based Study. Clin Infect Dis 2023;77:1329.
13. Yang B, Kim BG, Han K, Jung JH, Kim JH, Park DW, Kim SH, Kim EG, Sohn JW, Yoon HJ, Choi H, Lee H. Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study. Arthritis Res Ther 2023;25:209.
14. Kim T, Choi H, Lee H, Han K, Park DW, Park TS, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Impact of allergic disease on the risk of mycobacterial disease. J Allergy Clin Immunol Pract 2023;11:2830.
15. Choi H, Lee JY, Yoo H, Jeon K. Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis. Int J Mol Sci 2023;24:9362.
16. Kim Y, Yoon JH, Ryu J, Yang B, Chung SJ, Kang HK, Park DW, Park TS, Moon JY, Kim TH, Kim SH, Sohn JW, Yoon HJ, Lee H, Choi H. Gastroesophageal reflux disease increases susceptibility to non-tuberculous mycobacterial pulmonary disease. Chest 2023;163:270.
17. Choi H, Han K, Jung JH, Park SH, Kim SH, Kang HK, Sohn JW, Shin DW, Lee H. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clin Infect Dis 2023;76:e973.
18. Moon SM, Choi H, Kang HK, Lee SW, Sim YS, Park HY, Kwon YS, Kim SH, Oh YM, Lee H. Impacts of asthma in patients with bronchiectasis: findings from the KMBARC registry. Allergy Asthma Immunol Res 2023;15:83.
19. Choi H, Chalmers JD. Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention. Ann Transl Med 2023;11:25.
20. Choi H, Kim SH, Han K, Park TS, Park DW, Moon JY, Kim SH, Kim TH, Sohn JW, Yoon HJ, Lee H. Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis. Respir Res 2022;23:288.
21. Choi H, Yoo J, Han K, Lee H. Reply: Epithelial Mesenchymal Plasticity as a Potential Common Link between Lung Disease and Increased Risk of Lung Cancer [Letter]. Ann Am Thorac Soc 2022;19:1788.
22. Choi H, Park HY, Han K, Yoo J, Shin SH, Yang B, Kim Y, Park TS, Park DW, Moon JY, Ra SW, Kim TH, Kim SH, Oh YM, Yoon HJ, Sohn JW, Lee H. Non-Cystic Fibrosis Bronchiectasis Increases the Risk of Lung Cancer Independent of Smoking Status. Ann Am Thorac Soc 2022:19;1551.
23. Choi H, Yoo H, Lee JY, Park J, Jeon K. Plasma Mitochondrial DNA and Necroptosis as Prognostic Indicators in Critically Ill Patients with Sepsis. Biomedicines 2022;10:2386.
24. Choi H, Han K, Yang B, Shin DW, Sohn JW, Lee H. Female reproductive factors and incidence of non-tuberculous mycobacterial pulmonary disease among postmenopausal women in Korea. Clin Infect Dis 2022;75:1397.
25. Choi H, Park HA, Hyun IG, Kim JH, Hwang YI, Jang SH, Sim YS, Shin TR, Ko Y, Ban GY, Hong JY, Lee CY, Lee MG, Choi JH. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study. Pharmacoepidemiol Drug Saf 2022;31:1153.
26. Lee H, Kim Y, Yoon JH, Choi H. Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use? A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease Response [Letter]. Chest 2023;163:e148.
27. Kim Y, Han K, Yoo J, Kang HK, Park TS, Park DW, Hong JY, Moon JY, Kim SH, Kim TH, Yoo KH, Sohn JW, Yoon HJ, Choi H, Lee H. Risk Factors of Incident Lung Cancer in Patients with Non-Cystic Fibrosis Bronchiectasis: A Korean Population-Based Study. Cancers 2022;14:2604.
28. Lee H, Choi H, Jo YS. Trends in Influenza Vaccination Rates in Participants With Airflow Limitation: The Korea National Health and Nutrition Examination Survey 2007–2018. Front Med 2022;9:870617.
29. Yang B, Han K, Kim B, Kang HK, Kim JS, Kim EG, Choi H, Lee H. Association between Smoking Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study. J Pers Med 2022;12:691.
30. Kim T, Yoon JH, Yang B, Ryu J, Yoon CK, Kim Y, Sohn JW, Lee H, Choi H. Healthcare Utilization and Medical Cost of Gastrointestinal Reflux Disease in Non-tuberculous Mycobacterial Pulmonary Disease: A Population-Based Study, South Korea, 2009–2017. Front Med 2022;9:793453.
31. Park HY, Kang D, Shin SH, Choi H, Jang SH, Lee CH, Kim H, Kwon OJ, Rhee CK, Cho J. Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2022;19:640.
32. Choi H, Lee H, Ra SW, Jang JG, Lee JH, Jhun BW, Park HY, Jung JY, Lee SJ, Jo KW, Rhee CK, Kim C, Lee SW, Min KH, Kown YS, Kim DK, Lee JH, Park YB, Chung EH, Kim YJ, Yoo KH, Oh YM. Developing a Diagnostic Bundle for Bronchiectasis in South Korea: A Modified Delphi Consensus Study. Tuberc Respir Dis 2022;85:56.
33. Yoon JH, Kim SH, Ryu J, Chung SJ, Kim Y, Yoon CK, Ra SW, Oh YM, Choi H, Lee H. Gastro-oesophageal reflux disease increases healthcare use and medical costs in patients with bronchiectasis: a Korean nationwide population-based study. Therap Adv Gastroenterol 2021;14:17562848211062801.
34. Choi H, Yoo JE, Han K, Choi W, Rhee SY, Lee H, Shin DW. Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study. Front Nutr 2021;8:739766.
35. Choi H. Nosocomial exposure to tuberculosis: a snapshot of South Korea [Editorial]. Korean J Intern Med 2021;36:1061.
36. Lee H, Choi H, Lee SK, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Predicting Factors of Severe COVID-19 in Patients With Asthma: A Korean National Cohort Study. Allergy Asthma Immunol Res 2021;13:939.
37. Choi H, Ko Y, Lee CY, Chung SJ, Kim HI, Kim JH, Park S, Hwang YI, Jang SH, Jung KS, Kim YK, Park JY. Impact of COVID-19 on TB epidemiology in South Korea. Int J Tuberc Lung Dis 2021;25:854.
38. Choi H, Lee H, Ra SW, Kim HK, Lee JS, Um SJ, Kim SH, Oh YM, Kwon YS. Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry. J Clin Med 2021;10:4542.
39. Yang B, Han K, Kim SH, Lee DH, Park SH, Yoo JE, Shin DW, Choi H, Lee H. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021;13:3206.
40. Kim T, Lee H, Sim YS, Yang B, Park HY, Ra SW, Jang HJ, Yoo SJ, Kim SH, Sohn JW, Yoon HJ, Oh YM, Kwon YS, Choi H. Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study. J Thorac Dis 2021;13:4894.
41. Yang B, Choi H, Shin SH, Kim Y, Moon JY, Park HY, Lee H. Association of Ventilatory Disorders with Respiratory Symptoms, Physical Activity, and Quality of Life in Subjects with Prior Tuberculosis: A National Database Study in Korea. J Pers Med 2021;11:678.
42. Yang B, Kim T, Ryu J, Park HY, Hwangbo B, Kong SY, Kwon YS, Lee SJ, Ra SW, Oh YM, Sohn JW, Choe KH, Choi H, Lee H. Increased Incidence and Associated Risk Factors of Aspergillosis in Patients with Bronchiectasis. J Pers Med 2021;11:422.
43. Lee H, Choi H, Yang B, Lee SK, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J 2021;58:2004125.
44. Lee H, Choi H, Chalmers JD, Dhar R, Nguyen TQ, Visser SK, Morgan LC, Oh YM. Characteristics of bronchiectasis in Korea: First data from the Korean Multcentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries. Respirology 2021;26:619.
45. Choi H, Lee JK, Oh HJ, Kim MS, Kho BG, Park CK, Oh IJ, Kim YC. Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thorac Cancer 2021;12:1598.
46. Choi H, Yang B, Kim YJ, Sin S, Jo YS, Kim Y, Park HY, Ra SW, Oh YM, Chung SJ, Yeo Y, Park DW, Park TS, Moon JY, Kim SH, Kim TH, Yoon HJ, Sohn JW, Lee H. Increased mortality in patients with non cystic fibrosis bronchiectasis respiratory comorbidities. Sci Rep 2021;11:7126.
47. Choi H, Lee H, Lee SK, Yang B, Chung SJ, Yeo Y, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study. Ther Adv Respir Dis 2021;15.
48. Yang B, Ryu J, Kim T, Jo YS, Kim Y, Park HY, Kang YA, Lee SJ, Lee OJ, Moon JY, Ra SW, Kim SH, Kim TH, Kwon YS, Oh YM, Lee KM, Sohn JW, Yoon HJ, Choi H, Lee H. Impact of Bronchiectasis on incident NTM pulmonary disease: A 10-Year national cohort study. Chest 2021;159:1807.
49. Yang B, Choi H, Lee SK, Chung SJ, Yeo Y, Shin YM, Park DW, Park TS, Moon JY, Kim TH, Sim YS, Yoon HJ, Sohn JW, Lee H, Kim SH. Risk of Coronavirus Disease Incidence, Severe Presentation, and Mortality in Patients with Lung Cancer. Cancer Res Treat 2021;53:678.
50. Lee H, Choi H, Nam H, Yang B, Hwangbo B, Kong SY, Chung SJ, Yeo Y, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Body mass index change and incident asthma in adults: A nationwide cohort study. Allergy 2021;76:1896.
51. Chung SJ, Kim HI, Yang B, Kim T, Sim YS, Kang HK, Kim SH, Yoon HJ, Choi H, Lee H. Impact of the severity of restrictive spirometric pattern on nutrition, physical activity, and quality of life: results from a nationally representative database. Sci Rep 2020;10:19672.
52. Yang B, Jang HJ, Chung SJ, Yoo SJ, Kim T, Kim SH, Shin YM, Kang HK, Kim JS, Choi H, Lee H. Factors Associated Bronchiectasis in Korea: A National Database Study. Ann Transl Med 2020;8:1350.
53. Choi H, Ryu J, Kim Y, Yang B, Hwangbo B, Kong SY, Sim YS, Park HY, Ra SW, Oh YM, Moon JY, Kim TH, Kim SH, Sohn JW, Yoon HJ, Lee H. Incidence of Bronchiectasis concerning Tuberculosis Epidemiology and Other Ecological Factors: A Korean National Cohort Study. ERJ Open Res 2020;6:00097-2020.
54. Choi H, Lee H, Ryu J, Chung SJ, Park DW, Sohn JW, Yoon HJ, Kim SH. Bronchiectasis and Increased Mortality in Patients with Corticosteroid-Dependent Severe Asthma: a nationwide population study. Ther Adv Respir Dis 2020;14.
55. Choi H, Ko Y, Lee CY. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study. BMC Cancer 2020;20:825.
56. Lee H, Sohn JW, Sim YS, Shin TR, Kim DG, Choi H. Outcomes of Extended Duration Therapy for Drug-Susceptible Cavitary Pulmonary Tuberculosis. Ann Transl Med 2020;8:346.
57. Yang B, Choi H, Chung SJ, Shin B, Lee H, Park HY. Impact of Bronchiectasis on Postoperative Pulmonary Complications after Extra-pulmonary Surgery in Patients with Airflow Limitation. J Korean Med Sci 2020;35:e80.
58. Lee H, Choi H, Sim YS, Park S, Kim WJ, Yoo KH, Lee SJ, Kim TH, Yang B, Jeong I, Um SJ, Kim DK, Lee JH, Kwon BS, Cho YJ, Park HY, Lee CH, Rhee CK, Lee SH, Na JO, Jang AS, Jung JY, Ra SW, Lee JH, Kim SH, Kim C, Kim Y, Lee CY, Kim HK, Lee JS, Lee SW, Oh YM, KMBARC. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open 2020;10:e034090.
59. Yang B, Choi H, Lim JH, Park HY, Kang D, Cho J, Lee JS, Lee SW, Oh YM, Moon JY, Kim SH, Kim TH, Sohn JW, Yoon HJ, Lee H. The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. Ann Transl Med 2019;7:770.
60. Yang B, Choi H, Kim SH, Yoon HJ, Lee H. How will nanotechnology lead to better control of asthma? [Editorial] Ann Transl Med 2019;7:515.
61. Choi H, Ko UW, Lee H, Hong SB, Chung CR. Improved survival rates in patients with H1N1 acute respiratory failure in Korea between 2009 and 2016. PLoS One 2019;14:e0223323.
62. Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, Lee JS, Lee SW, Oh YM, Ra SW, Kim SH, Sohn JW, Yoon HJ, Lee H. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54:1900194.
63. Choi H, Shin B, Yoo H, Suh GY, Cho JH, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Jeon K. Early corticosteroid treatment for postoperative acute lung injury after lung cancer surgery. Ther Adv Respir Dis 2019;13:1753466619840256.
64. Choi H, Lee H, Jeon K, Suh GY, Shin S, Kim HK, Kim K, Jeong D, Kim H. Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis. J Thorac Dis 2019;11:892.
65. Choi H, Cho JH, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Jeon K. Prevalence and clinical course of postoperative acute lung injury after esophagectomy for esophageal cancer. J Thorac Dis 2019;11:200.
66. Kim S, Choi H, Jang YJ, Park SH, Lee H. Prevalence of and factors related to latent tuberculous infection among all employees in a referral hospital. Int J Tuberc Lung Dis 2018;22:1329.
67. Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. Diagn Microbiol Infect Dis 2018;90:293.
68. Choi H, Lee H, Jeong SH, Um SW, Kown OJ, Kim H. Pulmonary actinomycosis mimicking lung cancer on positron emission tomography. Ann Thorac Med 2017;12:121.
69. Choi H, Kim SY, Lee H, Jhun BW, Park HY, Jeon K, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin SJ, Daley CL, Koh WJ. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease. Antimicrob Agents Chemother 2017;61.
70. Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin S, Shin SJ, Daley CL, Koh WJ. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease. Antimicrob Agents Chemother 2017;61.
71. Choi H, Chon HR, Kim K, Kim S, Oh KJ, Jeong SH, Jung WJ, Shin B, Jhun BW, Lee H, Park HY, Koh WJ. Clinical and Laboratory Differences between Lymphocyte- and Neutrophil-Predominant Pleural Tuberculosis. PLoS One 2016;11:e0165428.
72. Choi H, Chang J, Shin HJ, Park CK, Oh IJ, Kim KS, Kim YC. Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma. Thorac Cancer 2015;6:224.
📌 Publications as the co-author
1. Gu KM, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park JS, Kim JY. Eosinophilia is a favorable marker for pneumonia in chronic obstructive pulmonary disease. Tuberc Respir Dis 2024;87:465.
2. Lee SH, Kim YJ, Oh J, Kang H, Yoo KH, Ko BS, Lim TH, Kim BG, Lee H, Kim SH, Sohn JW, Yoon HJ, Choi H, Cho Y, Park DW. The impact of pulmonary tuberculosis on SARS-CoV-2 infection: a nationwide cohort study. Front Med 2024;11:1416197.
3. Gao Y, Richardson H, Dicker AJ, Barton A, Kuzmanova E, Shteinberg M, Perea L, Goeminne PC, Cant E, Hennayake C, Pollock J, Abo Leyah H, Choi H, Polverino E, Blasi F, Welte T, Aliberti S, Long M, Shoemark A, Sibila O, Huang JTJ, Chalmers JD. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study. Am J Respir Crit Care Med 2024;210:77.
4. Cordeiro R, Choi H, Haworth CS, Chalmers JD. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis. Chest 2024;166:61.
5. Lee JS, Yang B, Shin HS, Lee H, Chai HG, Choi H, Han JH, Yoon JH, Kim EG, Lee H. Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study. ERJ Open Res 2024;10:00087.
6. Kim SJ, Kim T, Choi H, Shin TR, Kim HI, Jang SH, Hong JY, Lee CY, Chung S, Choi JH, Sim YS. Respiratory pathogen and clinical features of hospitalized patients in acute exacerbation of chronic obstructive pulmonary disease after COVID 19 pandemic. Sci Rep 2024;14:10462.
7. Yeo Y, Yoo JE, Han K, Jung JH, Choi H, Park J, Shin DW, Lee H. Risk of dementia in survivors of acute tuberculosis in Korea: A nationwide cohort study. J Infect Public Health 2024;17:286.
8. Choi W, Moon JH, Choi H, Lee H, Kim HK, Kang HC, Cho NH. Trajectory of lung function in diabetic adults: A 16-year follow-up study of community-based prospective cohorts. Respirology 2024;29:413.
9. Lee H, Kim SH, Lee SK, Choi H, Chung SJ, Park DW, Park TS, Moon JY, Kim TH, Kim SH, Sohn JW, Yoon HJ. Impact of air pollution on healthcare utilization in patients with bronchiectasis. Front Med 2023;10:1233516.
10. Kim JY, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park JS. The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study. Korean J Intern Med 2023;38:714.
11. Yoo JE, Choi H, Han K, Park SH, Park J, Lee H, Shin DW. Tuberculosis and risk of Parkinson's disease: A nationwide cohort study. Pulmonology 2023;29:250.
12. Kim T, Kim SJ, Choi H, Shin TR, Sim YS. Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer. Cancers 2023;15:2819.
13. Lee HR, Yoo JE, Choi H, Han K, Lim YH, Lee H, Shin DW. Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study. Clin Infect Dis 2023;76:1576.
14. Kim SR, Kim SH, Kim GH, Cho JY, Choi H, Lee H, Ra SW, Lee KM, Choe KH, Oh YM, Shin YM, Yang B. Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study. Front Med 2023;10:1159227.
15. Kim SH, Kim T, Choi H, Shin TR, Sim YS. Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19. J Clin Med 2023;12:2279.
16. Kim SH, Lee H, Joo H, Choi H, Sim YS, Rhee CK, Park YB, Kim Y, Yoo KH. Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study. J Korean Med Sci 2023;38:e3.
17. Kim T, Kim SJ, Choi H, Shin TR, Sim YS. Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer. Cancers 2023;15:2819.
18. Lee HR, Yoo JE, Choi H, Han K, Lim YH, Lee H, Shin DW. Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study. Clin Infect Dis 2023;76:1576.
19. Ahn EY, Choi H, Sim YS, Shin TR, Kim T. Pulmonary embolism and inferior vena cava thrombosis in a young male patient after mRNA-1273 (Moderna) immunization: A case report. Tuberc Respir Dis 2022;85:361.
20. Kim Y, Lee H, Lee SK, Yang B, Choi H, Park DW, Park TS, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Chronic Obstructive Pulmonary Disease is Associated with a More Symptomatic Burden and Severe Presentation of COVID-19: A Korean National COVID-19 Cohort Study. Tohoku J Exp Med 2022;256:209.
21. Lee H, Chung SJ, Kim SH, Choi H, Kim Y, Park TS, Park DW, Moon JY, Kim SH, Kim TH, Yoon HJ, Sohn JW. Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease. Front Med 2022;8:801206.
22. Yang B, Lee DH, Han K, Choi H, Kang HK, Shin DW, Lee H. Female Reproductive Factors and the Risk of Bronchiectasis: A Nationwide Population-Based Longitudinal Study. Biomedicines 2022;10:303.
23. Kim SH, Choi HS, Jin ES, Choi H, Lee H, Lee SH, Lee CY, Lee MG, Kim Y. Predicting severe outcome using national early warning score (NEWS) in patients identified by a rapid response system: a retrospective cohort study. Sci Rep 2021;11.
24. Jo YS, Han K, Kim D, Yoo JE, Kim Y, Yang B, Choi H, Sohn JW, Shin DW, Lee H. Relationship between total cholesterol level and tuberculosis risk a nationwide longitudianl cohort. Sci Rep 2021;11.
25. Yoo JE, Kim D, Choi H, Kang YA, Han K, Lee H, Shin DW. Anemia, sarcopenia, physical activity, and the risk of tuberculosis in the older population: a nationwide cohort study. Ther Adv Chronic Dis 2021;12.
26. Joo H, Moon JY, An TJ, Choi H, Park SY, Yoo H, Kim CY, Jeong I, Kim JH, Koo HK, Rhee CK, Lee SW, Kim SK, Min KH, Kim YH, Jang SH, Kim DK, Shin JW, Yoon HK, Kim DG, Kim HJ, Kim JW. Revised Korean Cough Guidelines, 2020: Recommendations and Summary statements. Tuberc Respir Dis 2021;84:263.
27. Kim SH, Choi H, Lee H, Hong JY, Kim Y. Predicting unexpected deterioration of high-risk hopitalized patients during the COVID-19 pandemic: A multicenter cohort study. Resuscitation 2021;163:14.
28. Kim T, Choi H, Shin TR, Ko Y, Park YB, Kim HI, Jang SH, Jung KS, Kim Y, Lee MG, Chung S, Kim CH, Hyun IG, Sim YS. Epidemiology and clinical features of common community human coronavirus disease. J Thorac Dis 2021;13:2288.
29. Kang HK, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park J, Kim JY. Hospitalization increases while economic status deteriorates in late stages of chronic obstructive pulmonary disease: the Korean National Health and Nutrition Examination Survey for 2007–2015. J Thorac Dis 2021;13:2160.
30. Gil HI, Yang B, Lee T, Kim MY, Choi H, Yoo H, Kim H, Kwon OJ, Chung SJ, Lee H. Clinical characteristics and treatment outcomes of Candida tracheobronchitis. Medicine (Baltimore) 2021;100:e24606.
31. Lee SJ, Ju S, You JW, Jeong YY, Lee JD, Kim HC, Choi H, Lee H, Oh YM, Ra SW. Trends in the Prevalence of Non-tuberculous Mycobacterial Infection in Patients with Non-Cystic Fibrosis Bronchiectasis in South Korea, 2012-2016. Chest 2021;159:959.
32. Kim HC, Suzuki M, Lim HF, Lan LTT, Nguyen HL, Wang JS, Lee KY, Lee JS, Oh YM, Lee SD, Choi H, Lee H, Lee SW. Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations. Korean J Intern Med 2021;36:1402.
33. Kim HK, Lee H, Kim SH, Choi H, Lee JH, Lee JS, Lee SW, Oh YM. Validation of the Korean Version of the Bronchiectasis Health Questionnaire. Tuberc Respir Dis 2020;83:228.
34. Yoon SH, Choi YD, Oh IJ, Kim KS, Choi H, Chang J, Shin HJ, Park CK, Kim YC. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer. Cancer Res Treat 2015;47:661.
35. Kim WJ, Kim S, Choi H, Chang J, Shin HJ, Park CK, Oh IJ, Kim KS, Kim YC, Choi YD. Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor. Thorac Cancer 2015;6:800.
36. Kim M, Chang J, Choi H, Oh IJ, Park CK, Kim YC, Choi YD, Yun JS, Song SY, Na KJ. Pulmonary epithelioid hemangioendothelioma misdiagnosed as a benign nodule. World J Surg Oncol 2015;13:10